Skip to main content

Antiretroviral therapy where resources are limited.

Publication ,  Journal Article
Reynolds, SJ; Bartlett, JG; Quinn, TC; Beyrer, C; Bollinger, RC
Published in: N Engl J Med
May 1, 2003

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

May 1, 2003

Volume

348

Issue

18

Start / End Page

1806 / 1809

Location

United States

Related Subject Headings

  • Practice Guidelines as Topic
  • Humans
  • HIV Infections
  • Global Health
  • General & Internal Medicine
  • Disease Outbreaks
  • Developing Countries
  • Antiretroviral Therapy, Highly Active
  • Anti-HIV Agents
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Reynolds, S. J., Bartlett, J. G., Quinn, T. C., Beyrer, C., & Bollinger, R. C. (2003). Antiretroviral therapy where resources are limited. N Engl J Med, 348(18), 1806–1809. https://doi.org/10.1056/NEJMsb035366
Reynolds, Steven J., John G. Bartlett, Thomas C. Quinn, Chris Beyrer, and Robert C. Bollinger. “Antiretroviral therapy where resources are limited.N Engl J Med 348, no. 18 (May 1, 2003): 1806–9. https://doi.org/10.1056/NEJMsb035366.
Reynolds SJ, Bartlett JG, Quinn TC, Beyrer C, Bollinger RC. Antiretroviral therapy where resources are limited. N Engl J Med. 2003 May 1;348(18):1806–9.
Reynolds, Steven J., et al. “Antiretroviral therapy where resources are limited.N Engl J Med, vol. 348, no. 18, May 2003, pp. 1806–09. Pubmed, doi:10.1056/NEJMsb035366.
Reynolds SJ, Bartlett JG, Quinn TC, Beyrer C, Bollinger RC. Antiretroviral therapy where resources are limited. N Engl J Med. 2003 May 1;348(18):1806–1809.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

May 1, 2003

Volume

348

Issue

18

Start / End Page

1806 / 1809

Location

United States

Related Subject Headings

  • Practice Guidelines as Topic
  • Humans
  • HIV Infections
  • Global Health
  • General & Internal Medicine
  • Disease Outbreaks
  • Developing Countries
  • Antiretroviral Therapy, Highly Active
  • Anti-HIV Agents
  • 42 Health sciences